ADVENTIA PHARMA , protagonist of the International Gastric Cancer Day held at the MD Anderson Cancer Center
The lack of a unique protocol for monitoring patients and the absence of specialists after the consequences that the disease entails, some of the deficiencies that the Association of Patients against Gastric and Gastrectomized Cancer (ACCGG) revealed during the day
On the occasion of the International Gastric Cancer Day which is celebrated every November 28, the national day of meeting of specialists and industry organized by the ACCGG took place in Madrid with the collaboration of MD Anderson Cancer Center and Adventia Pharma.
More than 7,800 new patients are affected each year by gastric cancer and healthcare professionals shared information about current treatments to access these types of tumors.
The president of the ACCGG, Pilar Ruiz, highlighted in turn the role of the association in helping patients and family members since the lack of a follow-up protocol after gastrectomy and lack of information are some of the shortcomings for that demand a solution.
Adventia Pharma participated in the day exposing its work of support for the creation of ACCGG and its continuity. To the assessment of Dr. Tamara Casañas, director of the medical department of the Spanish pharmaceutical laboratory, “from the beginning the philosophy of our company is to contribute with solutions that improve the quality of life of patients so the success of the Association is the confirmation that our model of listening to patients works ”.